Articles from Hanger, Inc.

Hanger Numotion will be formed through the combination of Hanger, Inc. (“Hanger”) and Numotion. Hanger is a leading provider of orthotic and prosthetic (“O&P”) patient care services and solutions. Numotion, a portfolio company of AEA Investors (“AEA”), is a leading provider of Complex Rehabilitation Technology (“CRT”) and mobility products and services in the U.S. and Canada. Following completion of the transaction, Hanger and Numotion will continue to serve customers under their existing brands and maintain their respective clinical operations. The transaction will be structured as an acquisition of Numotion for cash by Hanger. The combined company will be controlled by Patient Square Capital.

Hanger Ventures, a Hanger, Inc. business whose primary objective is to advance orthotics and prosthetics innovation and improve patient outcomes, today announced its debut investment in Bionic Power, a Canadian-based firm. A developer of active lower body smart orthotic devices that enhance personal mobility, Bionic Power is raising Series A Round funding, with Hanger Ventures committing as the lead investor.

Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today the launch of Hanger Ventures, a subsidiary designed to focus on accelerating innovation, developing technology, and improving patient outcomes worldwide. Using robust clinical expertise and scale, Hanger Ventures will invest in entrepreneurs and small businesses, helping to bring innovative O&P healthcare solutions to the market.

Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Pete Stoy, formerly the company’s President and Chief Operating Officer, has assumed the role of Hanger’s Chief Executive Officer (CEO), effective immediately. Stoy will also serve on Hanger’s Board of Directors.

Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Chairman and Chief Executive Officer (CEO) Vinit Asar will retire from the role of CEO effective May 1, 2023 after more than a decade in the position. In line with a multi-year succession plan, Hanger’s Chief Operating Officer (COO) Pete Stoy has been named President and COO, and will assume the role of CEO upon Asar’s retirement, in addition to serving on Hanger’s Board of Directors. At that time, Asar’s role will transition to Executive Chairman of Hanger’s Board, where he will assist with strategic initiatives, including mergers and acquisitions, and provide support for Stoy and the Board as needed.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on July 21, 2022, and Hanger’s stockholders approved the transaction at a Special Meeting of Stockholders held on September 30, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, which has been unanimously approved by Hanger’s Board of Directors, Hanger stockholders will receive $18.75 in cash per share, representing an approximately 29% premium to the 30 calendar day volume-weighted average price (VWAP) ending July 20, 2022, and a total enterprise value of approximately $1.25 billion. Upon completion of the transaction, Hanger will become a privately held company, and its common stock will no longer be traded on the New York Stock Exchange (NYSE).

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2022 after the stock market closes on Monday, August 8, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that members of its management team will participate in presentations and meetings at the Jefferies Healthcare Conference taking place June 8-10, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the first quarter ended March 31, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the first quarter and three months ended March 31, 2022 after the stock market closes on Wednesday, May 4, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of outcomes-based orthotic and prosthetic (O&P) patient care services and solutions, today celebrates being named one of America’s Best Midsized Employers by Forbes. The Austin-based company, comprised of nearly 5,000 employees, was selected through an independent nationwide survey of more than 60,000 American employees working for midsized to large companies. Respondents ranked their willingness to recommend current employers to friends and family, and had the option to nominate other notable organizations within their industry.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced a preliminary estimate of certain results for the year ended December 31, 2021. The Company also provided its initial financial outlook for the year ended December 31, 2022.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the third quarter and nine months ended September 30, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the third quarter and nine months ended September 30, 2021 after the stock market closes on Monday, November 8, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate virtually in presentations and meetings with institutional investors at the Baird 2021 Global Healthcare Conference taking place September 14-15, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2021 after the stock market closes on Wednesday, August 4, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate in presentations and meetings with institutional investors at the Jefferies Virtual Healthcare Conference taking place June 1-4, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate in presentations and meetings with institutional investors at the BofA Securities 2021 Healthcare Conference taking place virtually May 10-13, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the first quarter ended March 31, 2021.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the first quarter ended March 31, 2021 after the stock market closes on Wednesday, May 5, 2021.